Search
Close this search box.

The European Lead Factory selects first COVID-19 proposal

Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been looking for ways to contribute collective efforts and assets to help deal with the crisis. As part of this focus, we have decided to prioritise COVID-19 related proposals through a fast-track procedure. We’re proud to announce that the first proposal to tackle the SARS-CoV-2 infection has now been selected. The screening program aims to identify small-molecule inhibitors of viral entry into host cells.

The chosen proposal was submitted by Pivot Park Screening Centre (PPSC), located in Oss, the Netherlands. Following normal procedures, the proposal was evaluated by the Review Committee for scientific quality, degree of target validation, innovation, and treatment potential. The next steps will involve writing a comprehensive programme plan in consultation with experts from the European Screening Centre to retrieve the most promising hits.

Saman Honarnejad, Team Leader Assay Development at PPSC said: “If successful, this screening campaign can pave the way for the discovery of novel drug candidates that not only counteract disease progression in SARS-CoV-2 patients, but also protect against viral outbreaks.”

Commenting on this latest development, Jon de Vlieger, coordinator of the current project said: “We are thrilled to have made this selection and we’re excited that we can now begin work on a unique target mode. ELF has always carefully balanced its portfolio and made sure to address disease areas with high societal need. In addition to our global health programmes on neglected tropical diseases and antimicrobial resistance, we’re committed to contributing efforts to fight COVID-19 and other coronaviruses, by screening our unique compound collection on relevant drug targets in collaboration with the scientific community.”

Bron: European Lead Factory, 22 July 2020
https://www.europeanleadfactory.eu/node/347

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.